Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2741 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- MUC6 Antibody (Gastric Mucin)
- Antibody type
- Monoclonal
- Antigen
- A synthetic peptide of the gastric Mucin 6 tandem repeat sequence was used as the immunogen for the MUC6 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- CLH5
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the MUC6 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Alteration or adaptation, the two roads for human gastric mucin glycosylation infected by Helicobacter pylori.
Cystadenomas of the liver and extrahepatic bile ducts: Morphologic and immunohistochemical characterization of the biliary and intestinal variants.
Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Ductulo-insular pancreatic endocrine tumor with amyloid deposition: report of a case.
Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J
Journal of gastroenterology and hepatology 2015 Oct;30(10):1478-84
Journal of gastroenterology and hepatology 2015 Oct;30(10):1478-84
Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
Hashimoto T, Ogawa R, Matsubara A, Taniguchi H, Sugano K, Ushiama M, Yoshida T, Kanai Y, Sekine S
Histopathology 2015 Nov;67(5):689-98
Histopathology 2015 Nov;67(5):689-98
Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Abe T, Amano H, Shimamoto F, Hattori M, Kuroda S, Kobayashi T, Tashiro H, Ohdan H
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015 Nov;41(11):1515-21
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015 Nov;41(11):1515-21
Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R, Kohashi K, Takahashi S, Yamamoto H, Hirahashi M, Taguchi K, Nishiyama K, Oda Y
World journal of gastroenterology 2015 Mar 7;21(9):2700-10
World journal of gastroenterology 2015 Mar 7;21(9):2700-10
Alteration or adaptation, the two roads for human gastric mucin glycosylation infected by Helicobacter pylori.
Joncquel Chevalier Curt M, Lecointe K, Mihalache A, Rossez Y, Gosset P, Léonard R, Robbe-Masselot C
Glycobiology 2015 Jun;25(6):617-31
Glycobiology 2015 Jun;25(6):617-31
Cystadenomas of the liver and extrahepatic bile ducts: Morphologic and immunohistochemical characterization of the biliary and intestinal variants.
Albores-Saavedra J, Córdova-Ramón JC, Chablé-Montero F, Dorantes-Heredia R, Henson DE
Annals of diagnostic pathology 2015 Jun;19(3):124-9
Annals of diagnostic pathology 2015 Jun;19(3):124-9
Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V, Garrido M, Valente P, Ricardo S, Amaral AL, Barros R, Chaves P, Carneiro F, David L, Almeida R
Histopathology 2015 Feb;66(3):343-50
Histopathology 2015 Feb;66(3):343-50
Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Yamanoi K, Sekine S, Higuchi K, Kushima R, Nakayama J
Histopathology 2015 Dec;67(6):898-904
Histopathology 2015 Dec;67(6):898-904
Ductulo-insular pancreatic endocrine tumor with amyloid deposition: report of a case.
Shintaku M, Tado H, Inayama K, Murakami T, Suzuki T
Pathology international 2015 Apr;65(4):197-201
Pathology international 2015 Apr;65(4):197-201
Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Matsubara A, Ogawa R, Suzuki H, Oda I, Taniguchi H, Kanai Y, Kushima R, Sekine S
British journal of cancer 2015 Apr 14;112(8):1398-404
British journal of cancer 2015 Apr 14;112(8):1398-404
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human gastric carcinoma stained with MUC6 antibody (CLH5).
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of FFPE gastric carcinoma with MUC6 antibody (clone CLH5). HIER: steam section in pH6 citrate buffer for 20 min and allow to cool prior to testing.
